All Regulation articles – Page 28
-
Business
Reach reviewed: no change required
But disproportionate cost of compliance for small and medium size companies should be reduced, European commission says
-
Business
DCD in New Zealand milk
Dicyandiamide poses no food risk but fertiliser companies have suspended sales
-
Business
Flu vaccine without the eggs approved
Flublok does not require flu virus or eggs for manufacture
-
Business
UK companies struggling with Reach
Regulation is ‘elephant in the room’ as manufacturers fail to recognise implications
-
Business
EPA focuses on five chemicals
Risk assessments for five chemicals put out for public consultation
-
-
Business
TB drug milestone for bedaquiline
First TB drug with a new mechanism of action for 40 years wins approval
-
Business
Mango and Zara sign up to 'detox' plan
Greenpeace campaign to remove hazardous chemicals from the clothing industry is garnering big name support
-
Business
Approval for first gene therapy drug
Glybera (alipogene tiparvovec) injections have been approved in Europe
-
Business
Bomb chemicals face EU regulation
Retailers say chemical producers and distributors must share regulatory burden
-
Business
Regorafenib approved in US
Stivarga tablets approved for treatment of advanced colorectal cancer
-
Business
Measuring nano the European way
Report concludes that companies will need lots of methods to define nanomaterials
-
Business
Pineapple gel approved for burns
EU regulators approve NexoBrid gel from MediWound for removal of scab tissue
-
Business
Myelofibrosis drug approved in EU
Jakavi (ruxolitinib) tablets are for the treatment of myelofibrosis, a rare disease affecting the bone marrow
-
Business
Alzheimer's drug flops in Phase III
Solanezumab from Eli Lilly missed the cognitive and functional primary endpoints of the trials
-
Business
Generic Actos approved
Mylan, Ranbaxy and Teva have won US marketing approval for their generic versions of Actos diabetes tablets
-
Business
Bapineuzunab dropped
Development for the Alzheimer’s treatment stopped after clinical tests
-
-
Business
New cystic fibrosis drug in EU
Ivacaftor works by helping defective proteins function more normally
-
Business
New US chemical rules edge nearer
Chemical manufacturers would have to produce safety data for their products